Novo Nordisk
NVO
#109
Rank
HK$1.343 T
Marketcap
HK$304.76
Share price
-1.42%
Change (1 day)
-20.12%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): HK$179.91 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$51.43 Billion. In 2025 the company made an earning of HK$164.34 Billion, an increase over its 2024 earnings that were of HK$154.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$179.91 B9.47%
2025 HK$164.34 B6.28%
2024 HK$154.63 B28.01%
2023 HK$120.79 B57.81%
2022 HK$76.54 B5.24%
2021 HK$72.73 B12.38%
2020 HK$64.72 B13.11%
2019 HK$57.22 B-3.45%
2018 HK$59.26 B1.88%
2017 HK$58.17 B4.3%
2016 HK$55.77 B10.32%
2015 HK$50.55 B7.47%
2014 HK$47.04 B3.4%
2013 HK$45.49 B19.09%
2012 HK$38.20 B15.58%
2011 HK$33.05 B16.58%
2010 HK$28.35 B25.66%
2009 HK$22.56 B10.68%
2008 HK$20.38 B55.82%
2007 HK$13.08 B7.02%
2006 HK$12.22 B19.05%
2005 HK$10.26 B10.55%
2004 HK$9.28 B
2002 HK$6.14 B-14.39%
2001 HK$7.17 B-52.82%
2000 HK$15.21 B250%
1999 HK$4.34 B31.21%
1998 HK$3.31 B34.31%
1997 HK$2.46 B11.46%
1996 HK$2.21 B9.03%
1995 HK$2.02 B-3.15%
1994 HK$2.09 B-0.67%
1993 HK$2.10 B45.38%
1992 HK$1.45 B-13.81%
1991 HK$1.68 B37.12%
1990 HK$1.22 B-0.79%
1989 HK$1.23 B26.2%
1988 HK$0.98 B24.97%
1987 HK$0.78 B-0.9%
1986 HK$0.79 B-7.78%
1985 HK$0.85 B24.87%
1984 HK$0.68 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.63 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$272.60 B 51.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$61.06 B-66.12%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$88.84 B-50.70%๐Ÿ‡บ๐Ÿ‡ธ USA